Peer Review History
Original SubmissionFebruary 12, 2021 |
---|
PONE-D-21-04880 The prevalence, incidence and risk factors of mental health problems and mental health services use before and 9 months after the COVID-19 outbreak among the general Dutch population. A 3-wave prospective study. PLOS ONE Dear Dr. van der Velden, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Both reviewers found the topic of the research to be important and timely. They also agreed that the use of a large population-based longitudinal data set was a clear strength of the study. However, both reviewers raised some concerns about the lack of theoretical clarity for the rationale of the research, and noted that the rationale and findings could be better positioned within relevant social, epidemiological, and political contexts. Doing so would allow for more meaningful comparisons between the Dutch population and other relevant populations. These and other thoughtful comments from the reviewers should be given full and careful consideration in your revision. Please submit your revised manuscript by Jul 20 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Fuschia M. Sirois, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements.
https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I read this paper a few times, because as a reader I felt its presentation was confusing and I wanted to make sure I had not missed the point. For example, the introduction has sections delineated as ‘results’ which come before the methods section. I was unsure what these ‘results’ meant and why they came before the methods section. The research design was also unclear with different designs alluded to ranging from repeated measures in the abstract to prospective in the introduction, if it was a repeated measures prospective study it would have been clearer to use the same terminology throughout for consistency. There is clarity in the well-performed statistical analysis, but the rationale for the focus on mental health, sleep and medication use was unclear. I found the statement confusing about the lack of studies on sleep and COVID -19, because there are numerous studies on sleep and the relationship with COVID-19 including some longitudinal and some systematic reviews. Given how multi-factorial mental health is and the unique situation presented by the global pandemic, I wondered about the utility and how the interpretation of results could be used to positive effect within the field of mental health. I was also unsure as to the validity of an accurate comparison with the USA and UK when the measures differed between all the studies mentioned. Furthermore, in The Netherlands some questions failed to use validated measures, merely singular questions that were ‘similar’ to questions taken from validated measures. Within the discussion, specifically pages 30-31, rhetorical reasoning appears, for example, suggesting Brexit as a reason for higher UK scores, or societal tensions dividing the UK and USA, or even COVID-19 and the surrounding political discourse. Unfortunately, there is no scientific evidence presented for these claims, which I felt weakened the paper. Furthermore, suggesting support in health systems as a potential reason for differences in results is problematic when services are structured and funded differently. This again fails to address the complexity. Considering these claims overall left the discussion feeling somewhat unfocused, as if unsure of the story it wanted to tell. On arriving at the end of the paper, as a reader I wondered about originality and addition to the evidence base because of the previous papers using the same data set from the LISS panel and suggesting similar findings. Reviewer #2: This study examined the effects of COVID-19 pandemic on a comprehensive set of well-being outcomes including anxiety and depressive symptoms, sleep problems, fatigue, disabilities due to health problems, use of medicine for anxiety and depression, and mental health. Data were from the Longitudinal Internet studies for the Social Sciences (LISS) (N=4,064). This analysis is an extension to earlier covid related work using LISS investigating a longer time period and additional well-being outcome. Somewhat surprisingly, the authors found not significant increase in any of these outcomes. The authors conclude Dutch adults are resilient. While the study was well done, there are still some issues that need to be addressed: 1. It would be useful to provide more depth on the social, political, and epidemiological context in the Netherlands to provide more of a global perspective. Some of this is mention in the Discussion, but elaboration in the Introduction to "set the stage" would be most useful. - For example, how wide spread was testing? Mitigation efforts? Government response? Public opinion? 2. The authors speculate a bit for *why* there were no differences, yet other comparative countries, on balance, report lower well-being during pandemic. The reasons provided are not very well developed and need more fleshing out. This is a limitation in the paper. 3. Finally, what can the international community learn from the Dutch experience? 4. Another major limitation is there is not theoretical development in the Introduction of the paper. The authors briefly mention "conservation of resources" ... but how does that operate? Provided a theoretical framework will help with rationale for analytic approach, interpretation of results and providing additional substantive meaning. A few other, more minor, and editorial issues: a. Typo on pg 16. The authors mention NS for non-response, yet writ "p<.05" b. It would also be useful to know N with all 3 T, just 2, just T1 and T3 etc. c. Internet surveys have notorious low response rates. How was the sample chosen? What makes it representative of the Dutch population? These issues weren't spelled out in the Methods. d. The first paragraph of the Discussion simply repeats the aims; this needs reworking. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 1 |
PONE-D-21-04880R1The prevalence, incidence and risk factors of mental health problems and mental health services use before and 9 months after the COVID-19 outbreak among the general Dutch population. A 3-wave prospective study.PLOS ONE Dear Dr. van der Velden, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== ACADEMIC EDITOR:
For Lab, Study and Registered Report Protocols: These article types are not expected to include results but may include pilot data. ============================== Please submit your revised manuscript by Sep 23 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Marcus Tolentino Silva Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #3: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #3: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have done well to address comments so speedily and thoroughly. All queries have been answered satisfactorily. The paper now explains reasoning and substantiates the suggestions within the paper. Reviewer #3: - page 14: there is a typo, the range of the Cronbach alpha is 0 - 1, not 100. - measures need more description: are they validated tools? do they measure a construct or are they a checklist? if they measure a construct, what is the intarnal structure? - why were not calculated the cronbach alpha for all the measures? - Acronyms: - acronyms should be written in long form in the original language and then in their english form. - I do not see the extended form of the MOS acronym. - What does the acronym 'GEE' in the data analysis section means? - acronym aOR is repeated in its long form after declared in the short one - consider that p values cannot exceed 1, the authors may consider to report them without the zero before the decimal dot (APA-7 style). cross-wise meaning? - Table 4, 1: CIs of ORs need to be reported to understand the significance of results. - Table 4, 2: reading and intepreting this table is not straightforward, it is possible to use another format/way of presenting it? - in general, results are very detailed and I think that graphical representations of results are needed to give the readers information with an instant glance. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 2 |
PONE-D-21-04880R2The prevalence, incidence and risk factors of mental health problems and mental health services use before and 9 months after the COVID-19 outbreak among the general Dutch population. A 3-wave prospective study.PLOS ONE Dear Dr. van der Velden, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== ACADEMIC EDITOR: Please make the corrections marked by the reviewer. ============================== Please submit your revised manuscript by Oct 29 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Marcus Tolentino Silva Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #4: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #4: I Don't Know ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #4: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This paper is improved from my initial reading and the decision to rewrite the introduction means it now makes much more sense. However, there remain some flaws in the work, which could be addressed. Place the last paragraph on pp. 8-9 before the aim of the study so it flows neatly. Ethical approval/informed consent p. 10; it would probably be wise to give the reason why ethics was not needed; aggregated anonymised data. Agree with mentioning that participants had agreed for further analysis of their data. p.11, p. 16, Table 2, Table 3 etc.,: ‘disabilities due to mental health problems’. This could perhaps be worded as reduced or impaired functioning and use the ICF language. Disability using the social model refers to the barriers within society, used otherwise it places the ‘problem’ within the individual and makes the paper biomedical and lacking in consideration for social barriers. This makes people the problem. Means-Christensen et al. do not use the term disability in relation to psychological distress, they use impaired functioning (p. 566) which is the language of the ICF, as such the article is somewhat misrepresented. Likewise, reword mental health problems throughout the paper to mental health difficulties. Language is extremely important so we do not reify and marginalise groups. The term ‘eating problems’ could be amended. I thought these were eating disorders, are these identified by type in the LISS data? Then sleep problems are not identified, this could be a critique of the LISS data collection, does it mean disturbance in circadian rhythms, insomnia, or does it mean sleep disorders such as breathing-related sleep disorders? Alternatively, are a number of conditions/disorders aggregated under one heading? A little more clarity and critique here about the data would open the study out. p.22: 2nd sentence, should it not be that existing mental health difficulties and service use were the strongest predictor for continued mental health difficulties and service use before and after the COVID-19 pandemic? Services use should be service use throughout the paper, or use of services. Appreciate this a language issue. p.29, 2nd paragraph: ‘people who ran into mental health issues’ people experience mental health difficulties, they do not ‘run into them’ please amend. Limitations: this section goes further than strengths and limitations, so place some of this in a conclusion. Final remarks section: I am not convinced of the rationale in the comments in this section because I feel it adds little to the paper. Offering differences between the UK, Netherlands and USA (observed from other studies, not analysed statistically) was not the aim of the paper and adding these last six lines detracts from the work done. The conclusion needs to focus on the paper, summing it up and its addition/contribution to existing research. I would delete this section and rewrite. Perhaps call it conclusion rather than final remarks begin with prospective studies and use some of the limitation section, which is more suited to a conclusion section. For example, the results suggesting further research using clinical interviews to provide more insight and future studies on mental health difficulties, eating disorders etc. Reviewer #4: Dear authors, I consider the comments raised by the reviewers in the previous round of reviews were successfully addressed. Congratulations for your effort on that. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 3 |
The prevalence, incidence, and risk factors of mental health problems and mental health service use before and 9 months after the COVID-19 outbreak among the general Dutch population. A 3-wave prospective study. PONE-D-21-04880R3 Dear Dr. van der Velden, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Marcus Tolentino Silva Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
Formally Accepted |
PONE-D-21-04880R3 The prevalence, incidence, and risk factors of mental health problems and mental health service use before and 9 months after the COVID-19 outbreak among the general Dutch population. A 3-wave prospective study. Dear Dr. van der Velden: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Marcus Tolentino Silva Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .